What Experts Say About Us

Timothy E. Albertson, MD, MPH, PhD
The Journal of Thoracic Disease offers a dynamic platform to present cutting edge pulmonary and thoracic related research and observations. It is geared for rapid turnaround of submitted manuscripts. It has been a pleasure to work with this up-and-coming journal.
Timothy E. Albertson, MD, MPH, PhD
Editorial Board Member of JTD
Department of Internal Medicine, University of California, Davis, School of Medicine, Sacramento, CA, USA

 

Zaid Abdelsattar, MD, MS, FACS
It is with great pride and enthusiasm that I join the Journal of Thoracic Disease (JTD) in celebrating the tremendous growth milestone in earning an impact factor of 1.9 for the year 2024. As a member of the editorial board, I have experienced the journal's dedication, rigor, and collaborative spirit that have propelled JTD to this accomplishment. This reflects the journal’s growing influence and impact in the study of thoracic diseases, and its commitment to advancing science worldwide.

Since the journals inception, JTD has become a vital platform for disseminating cutting-edge research, fostering interdisciplinary collaboration, and addressing thoracic challenges in an open-access form available to all. I am particularly proud of our collective efforts to maintain rigorous peer review and amplify diverse ideas from researchers and clinicians worldwide.

Looking ahead, I envision JTD to continue this momentum. The rapid evolution of artificial intelligence and emerging technologies will be an area to focus on in future issues of JTD. As the journal grows, it remains important that we continue to support early-career researchers with mentorship and publication opportunities.

I extend my heartfelt gratitude to our authors, reviewers, editorial team, and readers for their invaluable contributions. Reflecting on past performances, I am assured that JTD can continue to shape the exciting future of thoracic surgery and medicine.
Zaid Abdelsattar, MD, MS, FACS
Editorial Board Member of JTD
Department of Thoracic & Cardiovascular Surgery, Loyola University Chicago, Maywood, IL, USA

 

Alexander C. Rokohl
Congratulations on AES’s First Impact Factor!

It is with great joy and admiration that I congratulate Annals of Eye Science on achieving its very first impact factor of 1.1. This milestone is not only a remarkable achievement for the journal itself, but also a reflection of the dedication, vision, and tireless efforts of the entire editorial team, reviewers, and contributors who have worked passionately to establish AES as a respected platform in the field of ophthalmology.

The journal’s rapid progress and growing reputation highlight its crucial role in fostering academic exchange, inspiring innovation, and advancing excellence in eye science and clinical practice. With its strong foundation and commitment to quality, I am confident that AES will continue to flourish and further strengthen its influence within the global scientific community.

I am truly honored to be part of the AES journey and look forward to witnessing many more milestones ahead. My warmest congratulations once again to the editors, authors, and readers of AES—may this be only the first of many achievements to come!
Alexander C. Rokohl, MD
Editorial Board Member and Author of AES
Center for Integrated Oncology Cologne and University Hospital of Cologne,
Cologne, Germany

 

Written on August 25, 2025

Etsuo Chihara
Congratulations on AES achieving an Impact Factor of 1.1 and a CiteScore of 1.6 for the year 2024, ranking 85th among 141 ophthalmological journals.

This remarkable accomplishment is undoubtedly the results of the dedicated efforts of your editorial team and reviewers.

In recent time, a tremendous volume of papers is being disseminated, however, what truly matters is the quality of the publications. I sincerely hope that AES will continue to contribute meaningfully to the advancement of ophthalmological knowledge and the improvement of eye care worldwide.
Etsuo Chihara, MD, PhD
Editorial Board Member and Guest Editor of AES
Sensho-kai Eye Institute, Kyoto, Japan
Shimane University, Izumo, Shimane, Japan

 

Written on August 4, 2025

Helena Prior Filipe
Heartfelt congratulations to the editorial team, authors, contributors, and reviewers of the journal on achieving an impact factor of 1.1. This is a well-deserved recognition, reflecting the scientific rigor of the articles published and the journal’s growing influence in shaping practice and guiding innovation across diverse ophthalmic disciplines.

I am confident the journal will continue to illuminate pathways for both seasoned professionals and the next generation of ophthalmologists, foster interdisciplinary dialogue, amplify voices from underrepresented regions, and embrace emerging themes such as artificial intelligence, simulation-based education, and patient-centered care.
Helena Prior Filipe, MD, MMEd
Editorial Board Member, Guest Editor and Author of AES
West Lisbon Hospitals Center (CHLO), Hospital of Egas Moniz,
Lisbon, Portugal;
Egas Moniz Center for Interdisciplinary Research (CiiEM),
Almada, Portugal

 

Written on August 4, 2025

Jacqueline Chua,
Congratulations to AES on achieving its first impact factor of 1.1! This milestone is a well-deserved recognition of the journal’s growing influence. Here's to many more years of success!
Jacqueline Chua, BOptom, PhD, FAAO
Editorial Board Member of AES
Duke-NUS Medical School,
Ocular Imaging Group, Singapore Eye Research Institute (SERI),
Singapore National Eye Centre (SNEC),
Singapore

 

Written on August 1, 2025